No apparent associations were observed between known cytogenetic and biologic features of the neuroblastoma cell lines, including MYCN amplification or other cytogenetic abnormalities or p53 mutations, and sensitivity to RXDX-105. The gene discussed is TP53; the disease is neuroblastoma.